Adaptive Biotechnologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADPT and other ETFs, options, and stocks.About ADPT
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines.
CEOChad Robins
CEOChad Robins
Employees619
Employees619
HeadquartersSeattle, Washington
HeadquartersSeattle, Washington
Founded2009
Founded2009
Employees619
Employees619
ADPT Key Statistics
Market cap1.99B
Market cap1.99B
Price-Earnings ratio-15.51
Price-Earnings ratio-15.51
Dividend yield—
Dividend yield—
Average volume2.00M
Average volume2.00M
High today$13.39
High today$13.39
Low today$12.58
Low today$12.58
Open price$12.68
Open price$12.68
Volume1.25M
Volume1.25M
52 Week high$13.39
52 Week high$13.39
52 Week low$3.98
52 Week low$3.98
ADPT News
TipRanks 4d
Adaptive Biotechnologies down 5% after Genentech pact terminatedShares of Adaptive Biotechnologies (ADPT) are down 60c, or 5%, to $12.44 after the company disclosed in a regulatory filing this morning that on August 13, the...
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
14.3%
Sell
0%
People also own
Based on the portfolios of people who own ADPT. This list is generated using Robinhood data, and it’s not a recommendation.